Berlin, December 7, 2022-Current recommendations on the supply bottleneck of nanoparticle albumin-bound paclitaxel (nab-paclitaxel)

被引：0
|
作者：
不详
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 02期
关键词：
PANCREATIC-CANCER; CHEMOTHERAPY; GEMCITABINE; FOLFIRINOX; SURVIVAL;
D O I：
10.1055/a-1998-7964
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [1] Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications
    Kudlowitz, David
    Muggia, Franco
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (06) : 681 - 685
  • [2] Dose-dense nab-paclitaxel (nanoparticle albumin-bound paclitaxel) in adjuvant chemotherapy for breast cancer: A feasibility study
    Burstein, H. J.
    Mayer, E. L.
    Peppercorn, J.
    Parker, L. M.
    Hannagan, K.
    Moy, B.
    Younger, J.
    Schapira, L.
    Wulf, G.
    Gelman, R.
    Winer, E. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?
    Palumbo, Raffaella
    Sottotetti, Federico
    Bernardo, Antonio
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2016, 8 (03) : 209 - 229
  • [4] NAB-PACLITAXEL ( NAB-P): nanoparticle albumin-bound paclitaxel: efficacy and toxicity evaluation: our experience in advanced pancreatic and breast cancer
    Burattini, E.
    Satta, F.
    Pellegrino, A.
    Todi, F.
    Zoffoli, M. V.
    Coiro, G.
    Marchetti, L.
    Di Palma, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration
    Chen, Nianhang
    Brachmann, Carrie
    Liu, Xiping
    Pierce, Daniel W.
    Dey, Joyoti
    Kerwin, William S.
    Li, Yan
    Zhou, Simon
    Hou, Shihe
    Carleton, Michael
    Klinghoffer, Richard A.
    Palmisano, Maria
    Chopra, Rajesh
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 699 - 712
  • [6] Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration
    Nianhang Chen
    Carrie Brachmann
    Xiping Liu
    Daniel W. Pierce
    Joyoti Dey
    William S. Kerwin
    Yan Li
    Simon Zhou
    Shihe Hou
    Michael Carleton
    Richard A. Klinghoffer
    Maria Palmisano
    Rajesh Chopra
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 699 - 712
  • [7] Final results of PEANUT: Pembrolizumab and nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC).
    Giannatempo, Patrizia
    Calareso, Giuseppina
    Bandini, Marco
    Marandino, Laura
    Raggi, Daniele
    Fare, Elena
    Colecchia, Maurizio
    Pederzoli, Filippo
    Gallina, Andrea
    Madison, Russell
    Briganti, Alberto
    Ross, Jeffrey S.
    Montorsi, Francesco
    Necchi, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Interim results of PEANUT: pembrolizumab and nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC)
    Necchi, Andrea
    Raggi, Daniele
    Bandini, Marco
    Fare, Elena
    Giannatempo, Patrizia
    Colecchia, Maurizio
    Pederzoli, Filippo
    Gallina, Andrea
    Marandino, Laura
    Calareso, Giuseppina
    Madison, Russell
    Briganti, Alberto
    Ross, Jeffrey S.
    Montorsi, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [9] nab-Paclitaxel (Abraxane®): an albumin-bound cytotoxic exploiting natural delivery mechanisms into tumors
    J Iglesias
    Breast Cancer Research, 11
  • [10] SPARC expression in head and neck cancer correlates with tumor response to nanoparticle albumin-bound paclitaxel (nab-paclitaxel, ABI-007, Abraxane)
    Trieu, Vuong
    Damascelli, Bruno
    Soon-Shiong, Patrick
    Desai, Neil
    CANCER RESEARCH, 2006, 66 (08)
12345